What defines a healthy gut microbiome?Matthias Van Hul, Patrice D Cani, Camille Petitfils, Willem M De Vos, Herbert Tilg, Emad M El-Omar
25 September 2024
Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBDGiorgos Bamias, Paola Menghini, Theresa T Pizarro, Fabio Cominelli
11 September 2024
Opening the doors of precision medicine: novel tools to assess intestinal barrier in inflammatory bowel disease and colitis-associated neoplasiaMarietta Iacucci, Giovanni Santacroce, Snehali Majumder, Jennifer Morael, Irene Zammarchi, Yasuharu Maeda, David Ryan, Antonio Di Sabatino, Maria Rescigno, Maria R Aburto, John F Cryan, Subrata Ghosh
8 June 2024
Emerging role of environmental pollutants in inflammatory bowel disease risk, outcomes and underlying mechanismsMaria Manuela Estevinho, Vishal Midya, Shirley Cohen-Mekelburg, Kristine Højgaard Allin, Mathurin Fumery, Salome S Pinho, Jean-Frederic Colombel, Manasi Agrawal
23 August 2024
Artificial intelligence applied to ‘omics data in liver disease: towards a personalised approach for diagnosis, prognosis and treatmentSoumita Ghosh, Xun Zhao, Mouaid Alim, Michael Brudno, Mamatha Bhat
22 August 2024
Nuclear receptors: pathophysiological mechanisms and drug targets in liver diseaseVanessa Dubois, Philippe Lefebvre, Bart Staels, Jerome Eeckhoute
11 June 2024
Intravital imaging: dynamic insights into liver immunity in health and diseaseYuting Wang, Felix Heymann, Moritz Peiseler
22 May 2024
Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinomaSuki Ha, Vincent Wai-Sun Wong, Xiang Zhang, Jun Yu
29 June 2024
Stomach microbiota in gastric cancer development and clinical implicationsRuijie Zeng, Hongyan Gou, Harry Cheuk Hay Lau, Jun Yu
17 June 2024
Coeliac disease: the paradox of diagnosing a food hypersensitivity disorder with autoantibodiesM Fleur du Pre, Rasmus Iversen, Ludvig M Sollid
20 February 2024